Clinical Trial Update: Mechanisms of Allergen Immunotherapy

View source ↗

Summary

NIAID-sponsored clinical trial investigating the mechanisms of allergen immunotherapy in asthma and hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Hypersensitivity

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma, Hypersensitivity | Status: COMPLETED